![](/rp/kFAqShRrnkQMbH6NYLBYoJ3lq9s.png)
CURE - Oncology & Cancer News for Patients & Caregivers
Warmth, Friendship and Compassion in Cancer Care. December 31st 2024. Carla Chapman, a nurse at Dana-Farber Cancer Institute, is recognized for her unwavering support of patients, while Deb Christensen, an oncologist and patient advocate, dedicates her life to helping patients through volunteer work and education.
Cancer Therapies Approved by the FDA in December 2024
2025年1月2日 · Imfinzi for Limited-Stage Small Cell Lung Cancer. Imfinzi (durvalumab) was approved for adults with limited-stage small cell lung cancer who have not experienced disease progression following concurrent platinum-based chemotherapy and radiation therapy.. The ADRIATIC trial showed that Imfinzi significantly improved both overall survival and progression-free survival (PFS) compared to placebo.
Cure Magazine - Curetoday
CURE provides access to the cancer news, latest oncology research & expert insights that serve as a guide to every stage of the cancer experience.
The Impact of Yescarta on Long Term Quality of Life in R/R …
2025年1月10日 · Dr. Sattva S. Neelapu, a professor and deputy department chair in the Department of Lymphoma/Myeloma, Division of Cancer Medicine, at The University of Texas MD Anderson Cancer Center, in Houston, as well as a member of Graduate Faculty, Immunology Program, Graduate School of Biomedical Sciences, at The University of Texas Health Science Center, also located in Houston, sat down for an ...
Top 5 Cancer Vaccine Stories from 2024 - curetoday.com
2024年12月25日 · Personalized cancer vaccines could be available for some patient populations as soon as next year, one expert said in an interview with CURE®. “We are way closer than we ever thought [we would be] just like three years ago,” said Dr. Patrick Ott, director of the Center for Personal Vaccines, clinical director of the Melanoma Disease Center and director of clinical sciences of the Center ...
Transurethral Ultrasound Ablation a Promising Prostate Cancer …
2024年10月14日 · Patients with prostate cancer demonstrated reduced tumor volume and PSA levels, a key marker of prostate cancer progression, and experienced improved urinary function and maintained sexual function after undergoing Transurethral Ultrasound Ablation (TULSA), according to a study presented at the CURE® Educated Patient® Prostate Cancer Summit by Dr. Yair Lotan, a professor of urology at UT ...
Top Lung Cancer Stories in 2024 - curetoday.com
2025年1月3日 · Cancer Vaccine for NSCLC Could Be Paradigm-Changing. New study results show that some patients with lung cancer and skin cancer maintained immune responses for 30 weeks after treatment with the mRNA-4157 cancer vaccine.. The phase 1 KEYNOTE-603 study, published in Cancer Discovery, showed that the combination of mRNA-4157 and Keytruda (pembrolizumab) produced anti-tumor responses in patients ...
TIL Therapy Uses the Body’s Own Cells to Attack Cancer Cells in …
2024年11月13日 · Key Takeaways. TIL therapy uses a patient's own T cells, expanded in vitro, to target cancer cells, offering a personalized treatment approach. Amtagvi (lifileucel) is the first FDA-approved TIL therapy for advanced melanoma, marking a …
Lymphedema Myths and Misconceptions, From Exercise to Blood …
2024年11月13日 · Key Takeaways. Lymphedema risk varies significantly by cancer type and lymph node removal extent, necessitating personalized risk assessments. Misconceptions about lymphedema precautions, such as avoiding blood pressure checks on …
How to Get the Most from Patient Portals During a Cancer Journey
2024年12月18日 · Key Takeaways. Electronic patient portals provide secure access to health information but require technological proficiency and appropriate devices for effective use.